Oct 24, 2026, 9:40 PM ETIDEX Corporation (IEX) StockDaniel JonesInvesting Group LeaderSummaryIDEX Corporation (IEX) continues to deliver robust revenue and profit growth across key segments, particularly Health & Science Technologies.Management raised 2026 organic revenue growth guidance to 5–6% and adjusted EPS to $8.70–$8.85, reflecting improved end-market demand.IEX's valuation remains elevated on both absolute and relative bases, limiting upside despite strong fundamentals and upgraded outlook.I reaffirm a ‘hold’ rating, awaiting a more attractive entry point given the current pricing versus peers and growth trajectory.Looking for a helping hand in the market? Members of Crude Value Insights get exclusive ideas and guidance to navigate any climate.